‘They’re planning my suspension’ — Natasha Akpoti accuses senate leadership of marginalisation
Natasha Akpoti-Uduaghan has accused the senate leadership of attempting to silence her. Speaking in an interview on Human Rights
All posts by Yuri Center
Read More »
Yuri Center
08:27
Trump sets Feb 18 for oil tariffs, plans lower duty for Canadian crude
A gas worker walks between pipes in a compressor and distribution station of the Urengoy-Pomary-Uzhgorod gas pipeline, some 30 km
Yuri Center
05:20
Public safety minister heading to Washington to convince Trump administration border is secure
Google News (Canada)Public safety minister heading to Washington to convince Trump administration border is secure National Post…Read More
Yuri Center
12:26
Treasure trove of unreleased Michael Jackson music found by retired cop
Treasure trove of unreleased Michael Jackson music found by retired cop
Yuri Center
20:21
Live Briefing: Rebels and government battle in Syria; Lebanon ceasefire fraying
Google News (Israel)Live Briefing: Rebels and government battle in Syria; Lebanon ceasefire fraying The Washington Post…Read More
Yuri Center
14:20
In Pictures: One beach, myriad tides
Every morning, Visakhapatnam’s Beach Road sheds its role as a roadway and transforms into a vibrant health hub dedicated to
Yuri Center
02:20
Celebrate the Festive Season with Holiday Afternoon Tea at Four Seasons Resort Orlando
The most wonderful time of the year is even more spectacular at Four Seasons Resort Orlando at Walt Disney World
Yuri Center
15:27
WATCH LIVE | DA heads to ConCourt over SA Citizenship Act ruling
The DA has gone to the Constitutional Court to seek an order of confirmation of the Supreme Court of Appeal
Yuri Center
13:34
OnePlus 13, Xiaomi 15, Honor Magic7 Pro unveiled, Week 44 in review
Last week Qualcomm unveiled the Snapdragon 8 Elite and this week we got the first phones with the flagship SoC.
Yuri Center
08:21
HighTide Therapeutics to Present Analyses of Phase 2 MASH Study at AASLD’s The Liver Meeting 2024
HONG KONG, Oct 25, 2024 - (ACN Newswire) - HighTide Therapeutics, Inc. (2511.HK), a clinical stage biopharmaceutical company specializing in the
